Innovar--nitrous oxide--oxygen: a four-year clinical appraisal of neuroleptanalgesia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001544:Benperidol / Q000009:adverse effects; D001919:Bradycardia / Q000139:chemically induced; D005260:Female; D005283:Fentanyl / Q000009:adverse effects / Q000494:pharmacology; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D009132:Muscles / Q000187:drug effects; D009294:Narcotics / Q000008:administration & dosage; D009325:Nausea / Q000453:epidemiology; D009458:Neuroleptanalgesia; D009609:Nitrous Oxide; D010100:Oxygen; D011182:Postoperative Care; D011183:Postoperative Complications; D011229:Preanesthetic Medication; D012119:Respiration / Q000187:drug effects; D013514:Surgical Procedures, Operative; D013997:Time Factors; D014839:Vomiting / Q000453:epidemiology
D009294:Narcotics; D001544:Benperidol; D009609:Nitrous Oxide; D010100:Oxygen; D005283:Fentanyl